Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

51.62 -0.26 (-0.50%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Crispr Therapeutics Ag

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
29 30 Next >
The 10 Best Stocks to Buy in April 2023
Here are 10 stocks to buy now that could unlock explosive gains in your growth-stock portfolio. 
Via The Motley Fool
Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics
Together, the companies could produce a game-changing product. 
Via The Motley Fool
5 Bargain-Basement Stocks to Buy Right Now
Down markets offer us something very positive: deals on quality companies. 
Via The Motley Fool
The 3 Best Growth Stocks to Buy in the Biotech Sector
These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors. 
Via InvestorPlace
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures
For those that can handle the heat, these biotech stocks to buy undergird some of the most powerful innovations in medicine. 
Via InvestorPlace
Why Bluebird Bio Shares Are Plunging Today
Via Benzinga
Could This Stock Become the Tesla of Its Industry?
It's in a race to a multi-billion dollar market. 
Via The Motley Fool
Expert Ratings for CRISPR Therapeutics
Via Benzinga
Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Could CRISPR Therapeutics Become the Next Moderna?
Both companies use cutting-edge technology. 
Via The Motley Fool
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it. 
Via InvestorPlace
3 Simple Ways to Supercharge Your Biopharma Investing Using Artificial Intelligence
Your stock screening and research process will never be the same. 
Via The Motley Fool
Expert Ratings for CRISPR Therapeutics
Via Benzinga
This Cathie Wood Stock Could Nearly Double, According to Wall Street
If the stock market continues to rally, this biotech could benefit. 
Via The Motley Fool
Thinking of Buying Biotech Stocks? Do These 3 Things First
It's better to plan ahead than to get caught by surprise. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
Via Benzinga
3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time
For investors betting on healthcare, look for these three companies to provide the treatments of tomorrow. 
Via InvestorPlace
3 Beaten-Down Stocks That Could Soar This Year
These stocks could enjoy big rebounds in 2023. 
Via The Motley Fool
2 Top Biotech Stocks to Buy for the Long Haul
These companies have what it takes to grow their revenues -- and their share prices -- over time. 
Via The Motley Fool
If You Invested $10,000 in CRISPR Therapeutics In 2020, This Is How Much You Would Have Today
The stock has been on a wild ride over the past few years. 
Via The Motley Fool
Missed Out on Vertex? My Best Gene-Editing Stock to Buy and Hold
Get in on CRISPR Therapeutics before it gets expensive. 
Via The Motley Fool
2 Healthcare Stocks That Could Help Make You a Fortune
These companies also happen to be a bargain right now. 
Via The Motley Fool
7 Cathie Wood Stocks for Your March Buy List
These top Cathie Wood stocks are just now attempting to pivot higher after a miserable outing for much of 2022. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Via Benzinga
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing
CRISPR Therapeutics, Beam Therapeutics and Vertex Pharmaceuticals are three CRISPR gene editing stocks you won't want to miss out on. 
Via InvestorPlace
Better Growth Stock: Moderna vs. CRISPR Therapeutics
Both stocks are ripe for a rebound. 
Via The Motley Fool
3 Things About CRISPR Therapeutics That Smart Investors Know
Institutional investors might be on to something. 
Via The Motley Fool
3 Game-Changing Stocks to Buy in March
Innovation is in these companies' DNA. 
Via The Motley Fool
2 Soaring Stocks to Buy and Hold Through 2023 and Beyond
Investors are bidding up shares of these companies, and there are good reasons for doing so. 
Via The Motley Fool
10 Best Stocks to Buy in March 2023
These diversified growth stocks could add rocket fuel to your long-term investment portfolio. 
Via The Motley Fool
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.